Richard T. Hume plans $10.6M SNX (NYSE: SNX) stock sale

Rhea-AI Filing Summary

Richard T. Hume has filed a notice of proposed sale of 66,848 shares of SNX common stock through Goldman Sachs & Co. LLC, with an indicated aggregate market value of 10,630,837.44. The shares are listed on the NYSE, with 80,729,152 shares outstanding.

The securities to be sold were originally acquired as compensation, including restricted stock units on 06/30/2020 and stock options on 10/05/2021, with a cashless exercise and same-day sale mechanism. Over the past three months, Hume has sold an additional 15,000 shares in three 5,000-share transactions.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Goldman Sachs & Co. LLC 200 West Street New York NY 10282	66848	10630837.44	80729152	01/28/2026	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	06/30/2020	Acquired as compensation -- Restricted Stock Units	Issuer			10000	06/30/2020	Compensation
Common	10/05/2021	Acquired as compensation -- Stock Options	Issuer			56848	10/05/2021	Compensation -- Cashless exercise / same-day sale

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Richard T. Hume 44201 Nobel Drive Fremont CA 94538	Common	11/03/2025	5000	769069
Richard T. Hume 44201 Nobel Drive Fremont CA 94538	Common	12/01/2025	5000	760551.5
Richard T. Hume 44201 Nobel Drive Fremont CA 94538	Common	01/05/2026	5000	768846.5

144: Remarks and Signature

Remarks

Date of Notice

Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does the Form 144 filing for SNX disclose about Richard T. Hume?

The filing shows Richard T. Hume plans to sell 66,848 SNX common shares through Goldman Sachs & Co. LLC. These shares were acquired as equity compensation, including restricted stock units and stock options granted in 2020 and 2021.

How large is Richard T. Hume’s planned SNX share sale under Rule 144?

The planned sale covers 66,848 SNX common shares with an indicated aggregate market value of 10,630,837.44. This sale relates to a company with 80,729,152 shares outstanding, as reported in the filing’s securities information table.

How were the SNX shares in Richard T. Hume’s Form 144 originally acquired?

The shares were acquired as equity compensation. Restricted stock units were granted on 06/30/2020, and stock options were granted on 10/05/2021, with a cashless exercise and same-day sale structure noted for the option-related shares.

What recent SNX share sales by Richard T. Hume are listed in the Form 144?

The filing lists three prior SNX common stock sales of 5,000 shares each on 11/03/2025, 12/01/2025, and 01/05/2026, with reported gross proceeds of 769,069, 760,551.5, and 768,846.5, respectively.

Which broker and exchange are involved in the planned SNX share sale?

The Form 144 states that Goldman Sachs & Co. LLC will act as broker, with its New York address provided. The SNX common shares are listed for trading on the New York Stock Exchange (NYSE) according to the securities information table.

What does the Form 144 say about Richard T. Hume’s knowledge of SNX’s information?

By signing the notice, the seller represents that they do not know any material adverse information about SNX’s current or prospective operations that has not been publicly disclosed, as required by the form’s standard attestation language.